Leadership
- Director, Office of Human Research
- Director, Clinical Research Unit
- Professor, SKMC Department of Pharmacology & Experimental Therapeutics
For Research Activities
- Senior Associate Provost, Research Conduct & Compliance
- Professor, SKMC Department of Pathology, Anatomy & Cell Biology
IRB Review Fees
Fees are assessed for full and expedited review of all formal IRB transactions for commercially funded research.
Fees are not assessed for non-federal grant-funded studies and Jefferson departmentally funded studies.
Commercially Sponsored Studies
Full Review Fees
| Full New Study Review | $3,200 |
| Full Review Amendment | $1,100 |
| Full Continuing Review | $1,625 |
Expedited Review Fees
| Expedited Review New Study | $1,575 |
| Expedited Review Amendment | $800 |
| Expedited Continuing Review | $1,625 |
Fees updated on 5/23/2018 and effective 6/1/18
Studies Conducted Under Commercial IRB Approval
The Jefferson IRB assesses a one-time fee of $2,500 for studies conducted under commercial IRB approval. This fee covers local processing and oversight activities.
NIH Single IRB Mandate for Multicenter Studies
Investigators submitting NIH applications for multisite research studies should contact the Office of Human Research well in advance of submitting the grant, to assist in determining which IRB will serve as the single IRB of record and the amount of the IRB fee to be included in the application.
This mandate applies to all competing grant applications due on or after January 25, 2018.